• 1
    Bica, I., Hamer, D. H. and Stadecker, M. J., Hepatic schistosomiasis. Infect. Dis. Clin. North. Am. 2000. 14: 583604, viii.
  • 2
    Cheever, A., Duvall, R., Hallack T., Jr., Minker, R., Malley, J. and Malley, K., Variation of hepatic fibrosis and granuloma size among mouse strains infected with Schistosoma mansoni. Am. J. Trop. Med. Hyg. 1987. 37: 8597.
  • 3
    Gause, W. C., Urban, J. F. and Stadecker, M. J., The immune response to parasitic helminths: insights from murine models. Trends Immunol. 2003. 24: 269277.
  • 4
    Pearce, E. J. and MacDonald, A. S., The immunobiology of schistosomiasis. Nat. Rev. Immunol. 2002. 2: 499511.
  • 5
    Stadecker, M. J., Asahi, H., Finger, E., Hernandez, H. J., Rutitzky, L. I. and Sun, J., The immunobiology of Th1 polarization in high-pathology schistosomiasis. Immunol. Rev. 2004. 201: 168179.
  • 6
    Rutitzky, L. I., Hernandez, H. J. and Stadecker, M. J., Th1-polarizing immunization with egg antigens correlates with severe exacerbation of immunopathology and death in schistosome infection. Proc. Natl. Acad. Sci. USA 2001. 98: 1324313248.
  • 7
    Rutitzky, L. I., Lopes da Rosa, J. R. and Stadecker, M. J., Severe CD4 T cell-mediated immunopathology in murine schistosomiasis is dependent on IL-12p40 and correlates with high levels of IL-17. J. Immunol. 2005. 175: 39203926.
  • 8
    Rutitzky, L. I., Bazzone, L., Shainheit, M. G., Joyce-Shaikh, B., Cua, D. J. and Stadecker, M. J., IL-23 Is Required for the Development of Severe Egg-Induced Immunopathology in Schistosomiasis and for Lesional Expression of IL-17. J. Immunol. 2008. 180: 24862495.
  • 9
    Langrish, C. L., McKenzie, B. S., Wilson, N. J., de Waal Malefyt, R., Kastelein, R. A. and Cua, D. J., IL-12 and IL-23: master regulators of innate and adaptive immunity. Immunol. Rev. 2004. 202: 96105.
  • 10
    Park, H., Li, Z., Yang, X. O., Chang, S. H., Nurieva, R., Wang, Y. H., Wang, Y. et al., A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat. Immunol. 2005. 6: 11331141.
  • 11
    Cua, D. J., Sherlock, J., Chen, Y., Murphy, C. A., Joyce, B., Seymour, B., Lucian, L. et al., Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 2003. 421: 744748.
  • 12
    Chen, Y., Langrish, C. L., McKenzie, B., Joyce-Shaikh, B., Stumhofer, J. S., McClanahan, T., Blumenschein, W. et al., Anti-IL-23 therapy inhibits multiple inflammatory pathways and ameliorates autoimmune encephalomyelitis. J. Clin. Invest. 2006. 116: 13171326.
  • 13
    Murphy, C. A., Langrish, C. L., Chen, Y., Blumenschein, W., McClanahan, T., Kastelein, R. A., Sedgwick, J. D. and Cua, D. J., Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 2003. 198: 19511957.
  • 14
    Nakae, S., Nambu, A., Sudo, K. and Iwakura, Y., Suppression of immune induction of collagen-induced arthritis in IL-17-deficient mice. J. Immunol. 2003. 171: 61736177.
  • 15
    Yen, D., Cheung, J., Scheerens, H., Poulet, F., McClanahan, T., McKenzie, B., Kleinschek, M. A. et al., IL-23 is essential for T cell-mediated colitis and promotes inflammation via IL-17 and IL-6. J. Clin. Invest. 2006. 116: 13101316.
  • 16
    Kullberg, M. C., Jankovic, D., Feng, C. G., Hue, S., Gorelick, P. L., McKenzie, B. S., Cua, D. J. et al., IL-23 plays a key role in Helicobacter hepaticus-induced T cell-dependent colitis. J. Exp. Med. 2006. 203: 24852494.
  • 17
    Mangan, P. R., Harrington, L. E., O'Quinn, D. B., Helms, W. S., Bullard, D. C., Elson, C. O., Hatton, R. D. et al., Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 2006. 441: 231234.
  • 18
    Zelante, T., De Luca, A., Bonifazi, P., Montagnoli, C., Bozza, S., Moretti, S., Belladonna, M. L. et al., IL-23 and the Th17 pathway promote inflammation and impair antifungal immune resistance. Eur. J. Immunol. 2007. 37: 26952706.
  • 19
    Caruso, R., Fina, D., Paoluzi, O. A., Del Vecchio Blanco, G., Stolfi, C., Rizzo, A., Caprioli, F. et al., IL-23-mediated regulation of IL-17 production in Helicobacter pylori-infected gastric mucosa. Eur. J. Immunol. 2008. 38: 470478.
  • 20
    Aggarwal, S., Ghilardi, N., Xie, M. H., de Sauvage, F. J. and Gurney, A. L., Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17. J. Biol. Chem. 2003. 278: 19101914.
  • 21
    Trinchieri, G., Pflanz, S. and Kastelein, R. A., The IL-12 family of heterodimeric cytokines: new players in the regulation of T cell responses. Immunity 2003. 19: 641644.
  • 22
    Brombacher, F., Kastelein, R. A. and Alber, G., Novel IL-12 family members shed light on the orchestration of Th1 responses. Trends Immunol. 2003. 24: 207212.
  • 23
    Veldhoen, M., Hocking, R. J., Atkins, C. J., Locksley, R. M. and Stockinger, B., TGFbeta in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 2006. 24: 179189.
  • 24
    Bettelli, E., Carrier, Y., Gao, W., Korn, T., Strom, T. B., Oukka, M., Weiner, H. L. and Kuchroo, V. K., Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006. 441: 235238.
  • 25
    Szabo, S. J., Kim, S. T., Costa, G. L., Zhang, X., Fathman, C. G. and Glimcher, L. H., A novel transcription factor, T-bet, directs Th1 lineage commitment. Cell 2000. 100: 655669.
  • 26
    Szabo, S. J., Sullivan, B. M., Stemmann, C., Satoskar, A. R., Sleckman, B. P. and Glimcher, L. H., Distinct effects of T-bet in TH1 lineage commitment and IFN-gamma production in CD4 and CD8 T cells. Science 2002. 295: 338342.
  • 27
    Rangachari, M., Mauermann, N., Marty, R. R., Dirnhofer, S., Kurrer, M. O., Komnenovic, V., Penninger, J. M. and Eriksson, U., T-bet negatively regulates autoimmune myocarditis by suppressing local production of interleukin 17. J. Exp. Med. 2006. 203: 20092019.
  • 28
    Bettelli, E., Sullivan, B., Szabo, S. J., Sobel, R. A., Glimcher, L. H. and Kuchroo, V. K., Loss of T-bet, but not STAT1, prevents the development of experimental autoimmune encephalomyelitis. J. Exp. Med. 2004. 200: 7987.
  • 29
    Gocke, A. R., Cravens, P. D., Ben, L. H., Hussain, R. Z., Northrop, S. C., Racke, M. K. and Lovett-Racke, A. E., T-bet regulates the fate of Th1 and Th17 lymphocytes in autoimmunity. J. Immunol. 2007. 178: 13411348.
  • 30
    Gao, J. L., Sen, A. I., Kitaura, M., Yoshie, O., Rothenberg, M. E., Murphy, P. M. and Luster, A. D., Identification of a mouse eosinophil receptor for the CC chemokine eotaxin. Biochem. Biophys. Res. Commun. 1996. 223: 679684.
  • 31
    Nagase, H., Miyamasu, M., Yamaguchi, M., Fujisawa, T., Kawasaki, H., Ohta, K., Yamamoto, K. et al., Regulation of chemokine receptor expression in eosinophils. Int. Arch. Allergy Immunol. 2001. 125: 2932.
  • 32
    Banchereau, J., Briere, F., Caux, C., Davoust, J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767811.
  • 33
    Langrish, C. L., Chen, Y., Blumenschein, W. M., Mattson, J., Basham, B., Sedgwick, J. D., McClanahan, T., et al., IL-23 drives a pathogenic T cell population that induces autoimmune inflammation. J. Exp. Med. 2005. 201: 233240.
  • 34
    Liang, S. C., Tan, X. Y., Luxenberg, D. P., Karim, R., Dunussi-Joannopoulos, K., Collins, M. and Fouser, L. A., Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J. Exp. Med. 2006. 203: 22712279.
  • 35
    Goerdt, S. and Orfanos, C. E., Other functions, other genes: alternative activation of antigen- presenting cells. Immunity 1999. 10: 137142.
  • 36
    Anthony, R. M., Rutitzky, L. I., Urban, J. F., Jr., Stadecker, M. J. and Gause, W. C., Protective immune mechanisms in helminth infection. Nat. Rev. Immunol. 2007. 7: 975987.
  • 37
    Vignali, D. A., Collison, L. W. and Workman, C. J., How regulatory T cells work. Nat. Rev. Immunol. 2008. 8: 523532.
  • 38
    Herbert, D. R., Holscher, C., Mohrs, M., Arendse, B., Schwegmann, A., Radwanska, M., Leeto, M. et al., Alternative macrophage activation is essential for survival during schistosomiasis and downmodulates T helper 1 responses and immunopathology. Immunity 2004. 20: 623635.
  • 39
    Hesse, M., Piccirillo, C. A., Belkaid, Y., Prufer, J., Mentink-Kane, M., Leusink, M., Cheever, A. W. et al., The pathogenesis of schistosomiasis is controlled by cooperating IL-10-producing innate effector and regulatory T cells. J. Immunol. 2004. 172: 31573166.
  • 40
    Taylor, J. J., Mohrs, M. and Pearce, E. J., Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J. Immunol. 2006. 176: 58395847.
  • 41
    Raes, G., De Baetselier, P., Noel, W., Beschin, A., Brombacher, F. and Hassanzadeh Gh, G., Differential expression of FIZZ1 and Ym1 in alternatively versus classically activated macrophages. J. Leukoc. Biol. 2002. 71: 597602.
  • 42
    Nair, M. G., Cochrane, D. W. and Allen, J. E., Macrophages in chronic type 2 inflammation have a novel phenotype characterized by the abundant expression of Ym1 and Fizz1 that can be partly replicated in vitro. Immunol. Lett. 2003. 85: 173180.
  • 43
    Loke, P., Nair, M. G., Parkinson, J., Guiliano, D., Blaxter, M. and Allen, J. E., IL-4 dependent alternatively-activated macrophages have a distinctive in vivo gene expression phenotype. BMC Immunol. 2002. 3: 7.
  • 44
    Pedras-Vasconcelos, J. A. and Pearce, E. J., Type 1 CD8+ T cell responses during infection with the helminth Schistosoma mansoni. J. Immunol. 1996. 157: 30463053.
  • 45
    Lugo-Villarino, G., Maldonado-Lopez, R., Possemato, R., Penaranda, C. and Glimcher, L. H., T-bet is required for optimal production of IFN-gamma and antigen-specific T cell activation by dendritic cells. Proc. Natl. Acad. Sci. USA 2003. 100: 77497754.
  • 46
    Guo, S., Cobb, D. and Smeltz, R. B., T-bet inhibits the in vivo differentiation of parasite-specific CD4+ Th17 cells in a T cell-intrinsic manner. J. Immunol. 2009. 182: 61796186.
  • 47
    Laan, M., Cui, Z. H., Hoshino, H., Lotvall, J., Sjostrand, M., Gruenert, D. C., Skoogh, B. E. and Linden, A., Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J. Immunol. 1999. 162: 23472352.
  • 48
    Witowski, J., Pawlaczyk, K., Breborowicz, A., Scheuren, A., Kuzlan-Pawlaczyk, M., Wisniewska, J. and Polubinska, A., IL-17 stimulates intraperitoneal neutrophil infiltration through the release of GRO alpha chemokine from mesothelial cells. J. Immunol. 2000. 165: 58145821.
  • 49
    Wurster, A. L., Rodgers, V. L., Satoskar, A. R., Whitters, M. J., Young, D. A., Collins, M. and Grusby, M. J., Interleukin 21 is a T helper (Th) cell 2 cytokine that specifically inhibits the differentiation of naive Th cells into interferon gamma-producing Th1 cells. J. Exp. Med. 2002. 196: 969977.
  • 50
    Irmler, I. M., Gajda, M. and Brauer, R., Exacerbation of antigen-induced arthritis in IFN-gamma-deficient mice as a result of unrestricted IL-17 response. J. Immunol. 2007. 179: 62286236.
  • 51
    Chu, C. Q., Swart, D., Alcorn, D., Tocker, J. and Elkon, K. B., Interferon-gamma regulates susceptibility to collagen-induced arthritis through suppression of interleukin-17. Arthritis Rheum. 2007. 56: 11451151.
  • 52
    Williams, A. S., Richards, P. J., Thomas, E., Carty, S., Nowell, M. A., Goodfellow, R. M., Dent, C. M. et al., Interferon-gamma protects against the development of structural damage in experimental arthritis by regulating polymorphonuclear neutrophil influx into diseased joints. Arthritis Rheum. 2007. 56: 22442254.
  • 53
    Wang, J., Fathman, J. W., Lugo-Villarino, G., Scimone, L., von Andrian, U., Dorfman, D. M. and Glimcher, L. H., Transcription factor T-bet regulates inflammatory arthritis through its function in dendritic cells. J. Clin. Invest. 2006. 116: 414421.
  • 54
    Juedes, A. E., Rodrigo, E., Togher, L., Glimcher, L. H. and von Herrath, M. G., T-bet controls autoaggressive CD8 lymphocyte responses in type 1 diabetes. J. Exp. Med. 2004. 199: 11531162.
  • 55
    Peng, S. L., Szabo, S. J. and Glimcher, L. H., T-bet regulates IgG class switching and pathogenic autoantibody production. Proc. Natl. Acad. Sci. USA 2002. 99: 55455550.
  • 56
    Neurath, M. F., Weigmann, B., Finotto, S., Glickman, J., Nieuwenhuis, E., Iijima, H., Mizoguchi, A., et al., The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J. Exp. Med. 2002. 195: 11291143.
  • 57
    Kleinschek, M. A., Owyang, A. M., Joyce-Shaikh, B., Langrish, C. L., Chen, Y., Gorman, D. M., Blumenschein, W. M. et al., IL-25 regulates Th17 function in autoimmune inflammation. J. Exp. Med. 2007. 204: 161170.
  • 58
    Wong, C. K., Lit, L. C., Tam, L. S., Li, E. K., Wong, P. T. and Lam, C. W., Hyperproduction of IL-23 and IL-17 in patients with systemic lupus erythematosus: implications for Th17-mediated inflammation in auto-immunity. Clin. Immunol. 2008. 127: 385393.
  • 59
    Fujiwara, M., Hirose, K., Kagami, S., Takatori, H., Wakashin, H., Tamachi, T., Watanabe, N. et al., T-bet inhibits both TH2 cell-mediated eosinophil recruitment and TH17 cell-mediated neutrophil recruitment into the airways. J. Allergy Clin. Immunol. 2007. 119: 662670.
  • 60
    Burrell, B. E., Csencsits, K., Lu, G., Grabauskiene, S. and Bishop, D. K., CD8+ Th17 mediate costimulation blockade-resistant allograft rejection in T-bet-deficient mice. J. Immunol. 2008. 181: 39063914.
  • 61
    Yuan, X., Paez-Cortez, J., Schmitt-Knosalla, I., D'Addio, F., Mfarrej, B., Donnarumma, M., Habicht, A. et al., A novel role of CD4 Th17 cells in mediating cardiac allograft rejection and vasculopathy. J. Exp. Med. 2008. 205: 31333144.
  • 62
    Sullivan, B. M., Jobe, O., Lazarevic, V., Vasquez, K., Bronson, R., Glimcher, L. H. and Kramnik, I., Increased susceptibility of mice lacking T-bet to infection with Mycobacterium tuberculosis correlates with increased IL-10 and decreased IFN-gamma production. J. Immunol. 2005. 175: 45934602.
  • 63
    Rosas, L. E., Snider, H. M., Barbi, J., Satoskar, A. A., Lugo-Villarino, G., Keiser, T., Papenfuss, T. et al., Cutting edge: STAT1 and T-bet play distinct roles in determining outcome of visceral leishmaniasis caused by Leishmania donovani. J. Immunol. 2006. 177: 2225.
  • 64
    Hultgren, O. H., Verdrengh, M. and Tarkowski, A., T-box transcription-factor-deficient mice display increased joint pathology and failure of infection control during staphylococcal arthritis. Microbes Infect. 2004. 6: 529535.
  • 65
    Ravindran, R., Foley, J., Stoklasek, T., Glimcher, L. H. and McSorley, S. J., Expression of T-bet by CD4 T cells is essential for resistance to Salmonella infection. J. Immunol. 2005. 175: 46034610.
  • 66
    Annacker, O., Pimenta-Araujo, R., Burlen-Defranoux, O., Barbosa, T. C., Cumano, A. and Bandeira, A., CD25+ CD4+ T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol. 2001. 166: 30083018.
  • 67
    Maloy, K. J., Salaun, L., Cahill, R., Dougan, G., Saunders, N. J. and Powrie, F., CD4+CD25+ T(R) cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med. 2003. 197: 111119.
  • 68
    Flores Villanueva, P. O., Chikunguwo, S. M., Harris, T. S. and Stadecker, M. J., Role of IL-10 on antigen-presenting cell function for schistosomal egg- specific monoclonal T helper cell responses in vitro and in vivo. J. Immunol. 1993. 151: 31923198.
  • 69
    Flores-Villanueva, P. O., Zheng, X. X., Strom, T. B. and Stadecker, M. J., Recombinant IL-10 and IL-10/Fc treatment down-regulate egg antigen- specific delayed hypersensitivity reactions and egg granuloma formation in schistosomiasis. J. Immunol. 1996. 156: 33153320.
  • 70
    Boros, D. and Warren, K., Delayed hypersensitivity-type granuloma formation and dermal reaction induced and elicited by a soluble factor isolated from schistosoma mansoni soluble eggs. J. Exp. Med. 1970. 132: 488507.
  • 71
    Rutitzky, L. I., Mirkin, G. A. and Stadecker, M. J., Apoptosis by neglect of CD4+ Th cells in granulomas: a novel effector mechanism involved in the control of egg-induced immunopathology in murine schistosomiasis. J. Immunol. 2003. 171: 18591867.